Intra-Cellular Therapies competitorsClear all

Intra-Cellular Therapies's top competitors include Microbion, Hancock Jaffe, PhaseBio Pharmaceuticals and Neofluidics.
Intra-Cellular Therapies
Intra-Cellular Therapies
Intra-Cellular Therapies develops drugs for the treatment of neuropsychiatric and neurologic diseases, and other disorders of the CNS.
Microbion
Microbion
Microbion is a pharmaceutical company developing therapeutics for the treatment of bacterial infections.
Hancock Jaffe
Hancock Jaffe
Hancock Jaffes is developing biologic-based solutions that are designed to be life enhancing for patients with cardiovascular disease, peripheral arterial and venous disease, and end stage renal disease (ESRD).
PhaseBio Pharmaceuticals
PhaseBio Pharmaceuticals
PhaseBio Pharmaceuticals is a biopharmaceutical company committed to developing new and improved drugs, with an initial focus on endocrine and metabolic disorders and cardiovascular disease.
Neofluidics
Neofluidics
Neofluidics is a company that develops tools and technology for enhanced microfluidics.
Founding Date
Founding Date
2002
Founding Date
2000
Founding Date
1987
Founding Date
2002
Founding Date
2014
Type
Type
Public
Type
Private
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
New York, US HQ
Locations
Bozeman, US HQ
Vancouver, CA
Locations
Irvine, US HQ
Locations
Malvern, US HQ
Locations
San Diego, US HQ
Employees
Employees
330352% increase
Employees
13
Employees
1233% increase
Employees
22
Employees
614% decrease
Valuation ($)
Valuation ($)
2.2 b
Valuation ($)
N/A
Valuation ($)
18.2 m
Valuation ($)
103 m
Valuation ($)
N/A
Twitter followers
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
141
Twitter followers
183
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
1
Number of tweets (last 30 days)
14
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
5
Average likes per tweet (last 30 days)
0.7
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
64.29%
Alexa Website Rank
Alexa Website Rank
375267
Alexa Website Rank
234907
Alexa Website Rank
164452
Alexa Website Rank
333886
Alexa Website Rank
N/A
Employee Rating
Employee Rating
5
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
5
Employee Rating
N/A

Financial

Revenue (est.)
Revenue (est.)
$60.6k (FY, 2019)
Revenue (est.)
N/A
Revenue (est.)
$31.2k (FY, 2019)
Revenue (est.)
$2.4m (FY, 2019)
Revenue (est.)
N/A
Net income
Net income
($147.7m) (FY, 2019)
Net income
N/A
Net income
($7.6m) (FY, 2019)
Net income
($39.2m) (FY, 2019)
Net income
N/A

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
$ 25m (over 3 years ago)
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 175k (about 3 years ago)
Total funding raised
Total funding raised
$ 225.3m
Total funding raised
$ 27.8m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 3.2m
For sources of this data, please see the company profile

View company profiles

Microbion
HQ
Bozeman, US
Employees
13

Microbion is a pharmaceutical company developing therapeutics for the treatment of bacterial infections.

View company
Hancock Jaffe
HQ
Irvine, US
Employees
12↑ 33% increase

Hancock Jaffes is developing biologic-based solutions that are designed to be life enhancing for patients with cardiovascular disease, peripheral arterial and venous disease, and end stage renal disease (ESRD).

View company
PhaseBio Pharmaceuticals
HQ
Malvern, US
Employees
22

PhaseBio Pharmaceuticals is a biopharmaceutical company committed to developing new and improved drugs, with an initial focus on endocrine and metabolic disorders and cardiovascular disease.

View company
Neofluidics
HQ
San Diego, US
Employees
6↓ 14% decrease

Neofluidics is a company that develops tools and technology for enhanced microfluidics.

View company